Publications
- Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis2021 | First Faculty of Medicine
- A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS2019 | First Faculty of Medicine
- Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study2018 | First Faculty of Medicine
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | First Faculty of Medicine
- Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis2017 | First Faculty of Medicine
- Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients2017 | First Faculty of Medicine
- A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients2016 | First Faculty of Medicine
- Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a2015 | First Faculty of Medicine
- Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome2015 | First Faculty of Medicine
- MRI correlates of disability progression in patients with CIS over 48 months2014 | First Faculty of Medicine, Faculty of Physical Education and Sport
Loading network view...